RIVA-Olanzapine (2015-02-18)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| C1362 | B. RIVA-Olanzapine 5 mg | - Recalling Firm
- Laboratoire Riva Inc.
- 660 Industrial Blvd.
- Blainville
- J7C 3V4
- Quebec
- CANADA
- Marketing Authorization Holder
- Laboratoire Riva Inc.
- 660 Industrial Blvd.
- Blainville
- J7C 3V4
- Quebec
- CANADA
| Tablet | DIN 02337134 | Olanzapine 5 mg |
| C1729, C0940 | C. RIVA-Olanzapine 7.5 mg | - Recalling Firm
- Laboratoire Riva Inc.
- 660 Industrial Blvd.
- Blainville
- J7C 3V4
- Quebec
- CANADA
- Marketing Authorization Holder
- Laboratoire Riva Inc.
- 660 Industrial Blvd.
- Blainville
- J7C 3V4
- Quebec
- CANADA
| Tablet | DIN 02337142 | Olanzapine 7.5 mg |
| C0938 | A. RIVA-Olanzapine 2.5 mg | - Recalling Firm
- Laboratoire Riva Inc.
- 660 Industrial Blvd.
- Blainville
- J7C 3V4
- Quebec
- CANADA
- Marketing Authorization Holder
- Laboratoire Riva Inc.
- 660 Industrial Blvd.
- Blainville
- J7C 3V4
- Quebec
- CANADA
| Tablet | DIN 02337126 | Olanzapine 2.5 mg |
Recalled Products
A. RIVA-Olanzapine 2.5 mg
B. RIVA-Olanzapine 5 mg
C. RIVA-Olanzapine 7.5 mg
This lot is potentially contaminated with foreign tablets (Ondansetron 8mg).